Yes, meloxicam can make you constipated. It is an uncommon but well-documented side effect, reported in roughly 1 to 5 percent of people taking the drug in clinical trials. Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID), and this whole drug class slows the gut, reduces intestinal fluid secretion, and can disrupt the bacteria and electrolytes that keep stool moving. Most cases are mild and appear within the first one to two weeks of starting or raising the dose, and they usually respond to fiber, fluids, and movement rather than stopping the medication.

The mechanism: why an arthritis drug slows the gut

Meloxicam works by blocking cyclooxygenase enzymes, mostly COX-2, which cuts prostaglandin production and reduces the inflammation driving arthritis pain. The problem is that prostaglandins are not only inflammatory messengers. They are also local hormones that keep the intestinal lining active, so blocking them has downstream consequences in the bowel.

Prostaglandins, particularly PGE2, stimulate intestinal smooth-muscle contraction and promote chloride and water secretion into the gut lumen. When meloxicam suppresses them, peristalsis weakens and the stool that reaches the colon carries less water. Less water plus slower transit equals harder, drier stool. This is a direct pharmacological effect, not an allergic reaction, which is why it can occur in anyone at any dose.

There is a second layer. NSAIDs can cause low-grade intestinal inflammation and increased gut permeability, sometimes called NSAID enteropathy. This shifts the gut microbiome and, in some people, changes the colonic environment enough to alter motility. In plain terms: meloxicam turns down a chemical signal the bowel relies on to keep things moving and moist.

A third, indirect path matters for chronic users. Meloxicam is often taken for osteoarthritis or rheumatoid arthritis, conditions treated alongside reduced activity, lower fluid intake, and sometimes opioid or calcium-channel-blocker co-medication. Each of those independently slows transit, so the drug and the lifestyle around it can compound.

How common is constipation on meloxicam?

Constipation sits among the less frequent gastrointestinal complaints for meloxicam. In the drug's controlled trial data summarized by the FDA, gastrointestinal effects such as dyspepsia, nausea, and diarrhea are more common, and constipation appears at low single-digit rates. Real-world rates run higher because trials undercount mild symptoms people never report.

Symptom on meloxicam Typical reported frequency Notes
Dyspepsia / heartburn Common, up to about 10 percent Most frequent GI complaint
Nausea Common Often early in treatment
Diarrhea Common Sometimes alternates with constipation
Abdominal pain Common Can coexist with constipation
Constipation Uncommon, roughly 1 to 5 percent Usually mild, dose-related
Serious GI bleeding Rare, under 1 percent Risk rises with age and duration

The comparison worth knowing: meloxicam's constipation rate is lower than that of many opioid painkillers, where constipation affects 40 to 80 percent of users, and lower than tricyclic antidepressants, which cause it in roughly 10 to 25 percent. So meloxicam is a mild offender, not a notorious one. That matters because people often blame the wrong drug.

Meloxicam constipation timeline: when it starts and when it resolves

The time course is fairly predictable. Constipation linked to meloxicam typically appears within days to two weeks of starting the drug or increasing the dose. If you have taken meloxicam for months without bowel changes, it is unlikely to suddenly be the cause unless something else shifted.

Phase Timeframe What typically happens
Start of therapy Day 1 to 3 Most people notice nothing; bowel habit unchanged
Early window Day 3 to 14 Constipation most likely to first appear here
Dose increase Within 1 to 2 weeks of change Risk rises with higher daily dose
Established use Week 2 to 8 Bowel adapts in many; symptoms settle or persist
Persistent cases Beyond 8 weeks Suggests compounding factors; reassess
After stopping 2 to 7 days Transit usually normalizes within about a week

If constipation begins after you have been on a stable meloxicam dose for six months, look elsewhere first: new medications, dehydration, thyroid change, or dietary shifts are more probable causes. This is a key correction to a common assumption that any bowel change on a chronic drug is the drug's fault.

Who is at higher risk, and the dose question

Dose matters. Meloxicam is typically prescribed at 7.5 mg or 15 mg daily, with 15 mg as the usual ceiling for osteoarthritis and 7.5 mg often used in people at higher GI risk. Higher dose and longer duration both raise the chance of gut side effects, including constipation. The 15 mg dose carries more GI risk than 7.5 mg across the class.

Several groups are more vulnerable. People over 65 have slower baseline transit and more polypharmacy. Anyone already prone to constipation, including those with irritable bowel syndrome with constipation, feels the effect more. People taking meloxicam alongside opioids, anticholinergics, calcium-channel blockers, or iron supplements stack multiple slowing mechanisms. Dehydration from diuretics or hot weather worsens stool hardness.

There is a professional caveat worth stating plainly: meloxicam is not a benign drug for the gut overall. Its most serious GI risk is not constipation but ulceration and bleeding, which is why the FDA boxed warning emphasizes GI risk and why the lowest effective dose for the shortest time is the standard guidance. Constipation is the nuisance symptom; bleeding is the dangerous one.

Constipation vs. something more serious: red flags

Constipation from meloxicam is uncomfortable but usually harmless. Some bowel changes are not, and NSAIDs can cause serious intestinal problems that mimic or accompany constipation. Watch for these warning signs and seek care promptly:

  • Black, tarry stools or blood in the stool, which can signal GI bleeding.
  • Severe or worsening abdominal pain, especially localized pain.
  • Vomiting, fever, or a rigid, tender abdomen.
  • Inability to pass stool or gas for more than three days with bloating.
  • New constipation with unexplained weight loss or anemia.
  • Chest pain, shortness of breath, or swelling, which can accompany NSAID cardiovascular effects.

These signs override any self-management plan. Meloxicam's serious GI and cardiovascular risks are why it is not recommended for everyone, and new severe symptoms deserve a clinician, not a home remedy.

What to actually do about meloxicam constipation

Most cases resolve with simple measures, and the goal is to keep the arthritis benefit while restoring bowel function. Start with the least invasive steps and escalate only if needed.

Increase fluid intake to roughly 2 liters (about 64 ounces) of water daily unless you have a fluid-restriction condition. Add soluble fiber gradually, targeting 25 to 30 grams daily from oats, beans, fruit, and vegetables, and increase it slowly to avoid gas. Move daily, since even a 20-minute walk stimulates colonic motility. Establish a regular toilet routine, ideally after breakfast when the gastrocolic reflex is strongest.

If lifestyle steps fall short, an over-the-counter osmotic laxative such as polyethylene glycol is generally preferred over stimulant laxatives for drug-related constipation because it is gentler and non-habit-forming. Discuss any laxative with a pharmacist or clinician, since some interact with other medications. Do not stop meloxicam abruptly on your own if you take it for a serious inflammatory condition; instead, ask about dose reduction or a switch.

The alternatives comparison: what to try if meloxicam constipates you

If constipation persists despite fixes, the question becomes what to change. The table below compares realistic options for someone whose arthritis is well controlled on meloxicam but whose gut is not.

Option Constipation risk GI bleeding risk Trade-off
Continue meloxicam + bowel regimen Low to moderate, manageable Unchanged Keeps pain control; requires daily effort
Lower meloxicam dose (15 mg to 7.5 mg) Lower Lower May reduce pain relief
Switch to a different NSAID Similar class risk Similar Little advantage; constipation can persist
Add a proton pump inhibitor Unchanged constipation Lower bleeding risk Extra pill; does not fix constipation
Topical NSAID gel Minimal systemic constipation Minimal Only for localized joint pain
Acetaminophen instead Very low Very low Weaker for inflammatory pain

The non-obvious point: switching from meloxicam to another oral NSAID like ibuprofen or naproxen rarely solves constipation, because the gut-slowing mechanism is a class effect. If the bowel problem is truly the drug, the meaningful moves are dose reduction, a topical route for localized pain, or a non-NSAID alternative, decided with a clinician. Constipation is not a reason to abandon pain control, but it is a reason to reassess the plan.

Limitations and what the evidence cannot tell us

The honest limits matter. Constipation rates for meloxicam come largely from pre-marketing trials that relied on patient reporting, so true incidence is uncertain and probably undercounted. There is no large study isolating meloxicam's constipation risk from the conditions and co-medications of the people who take it. Much of the mechanism is established pharmacology, but the exact size of the effect in any one person is not predictable.

In plain terms: the drug can slow your gut, the effect is usually mild and early, and the fix is mostly behavioral. If constipation is severe, persistent beyond a few weeks, or comes with any red-flag sign, treat it as a reason to talk to your clinician rather than a reason to quietly stop a medication that is helping your joints. The three numbers to remember are simple: constipation appears in roughly 1 to 5 percent of users, most often within 1 to 2 weeks, and usually eases within about a week of stopping.